🇺🇸 FDA
Patent

US 10220046

Compositions and methods for disease treatment using nanoparticle delivered compounds

granted A61KA61K31/58A61K31/585

Quick answer

US patent 10220046 (Compositions and methods for disease treatment using nanoparticle delivered compounds) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/58, A61K31/585, A61K38/1709, A61K9/16